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Toxoplasmosis represents the most frequent complica-
tion affecting the CNS of AIDS patients.
In Europe and South America the prevalence of toxo-
plasmosis is higher than in the United States (50-75% to
15%), so the risk for the AIDS-associated toxoplasmosis
is higher in this area, including Romania.
Most of the AIDS patients have immunoglobulin G
antibodies anti-Toxoplasma in their serum, like in the
general population, so most of the cases represent a
reactivation of a latent infection.
We present a series of 5 cases with patients, aged
between 19-29 years old, who developed cerebral
toxoplasmosis.
Three of the patients are multi-experienced, and for
two patients the cerebral toxoplasmosis was the defining
AIDS infection.
Three patients had a CD4 count under 100 cells/cmm
at the moment of their diagnosis, with low adherence
for cART and for the prophylaxis with trimethoprim-
sulfamethoxazole.
All patients but one had detectable HIV viral load.
Two of the patients are positive for B hepatitis, one of
them also for hepatitis D.
The clinical manifestations were persistent headache,
confusion, lethargy, hemiparesis.
All patients presented high levels for immunoglobulin
G anti-Toxoplasma at the moment of the clinical mani-
festations, one patient presented immunoglobulin M
anti-Toxoplasma.
The MRI examinations revealed characteristic multiple
lesions.
The treatment was performed using trimethoprim-sul-
famethoxazole for 6 weeks.
The evolution of the patients under the treatment was
favorable for all the patients, with the remission of the
symptoms and without neurological complications; they
received trimethoprim-sulfamethoxazole prophylaxis
until their CD4 >200/cmm, for another three months
Although difficult to diagnose, cerebral toxoplasmosis
is treatable and curable, despite of all the associated
AIDS pathology.
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